Raphael Bernier is professor of psychiatry at the University of Washington and clinical director of the Seattle Children’s Autism Center.
Raphael Bernier
Assistant Professor
University of Washington, Seattle
From this contributor
Through play, children with autism can hone thinking skills
Clinicians can use play to deliver therapies that could improve a child’s social skills, language and certain cognitive capacities.
Through play, children with autism can hone thinking skills
By
Raphael Bernier
31 May 2016 | 6 min read
Best practices
Guidelines for the use of electroencephalography in autism will ensure that researchers have a common set of standards, which will speed up discovery, say Sara Jane Webb and Raphael Bernier.
How do we measure autism severity?
Accurately measuring the severity of autism remains a challenge for the field. The answer may lie in using more than one approach that varies depending on whether it is being applied in a clinical or research context, says Raphael Bernier.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read